You're viewing a public preview of Virbac SA - SENTINEL U.S. Rights Sign up free to access full investment history, financials, executives & more
Sign Up Free Log In

Virbac SA - SENTINEL U.S. Rights

Inactive
New Jersey (NJ),  United States
Sector: Life Science Entity: Private
Merged Virbac SA - SENTINEL U.S. Rights merged into Merck & Co., Inc. in 2020
2
Transactions
Sign up to view
$400M
Deal Value
Sign up to view
About Virbac SA - SENTINEL U.S. Rights
According to available private market data, Virbac SA - SENTINEL U.S. Rights operates in the Life Science sector. Private market activity associated with the company includes investment from Merck & Co., Inc.. The company is headquartered in New Jersey (NJ). Virbac SA - SENTINEL U.S. Rights is included in the AcquityData private market database.
Investors
Current Investors
Merck & Co., Inc. ••••••••
Past Investors
•••••••• ••••••••
View Full Investor List
Sign up to see all current & past investors with deal dates and transaction details
Sign Up Free Log In
Investment Details
2 Transactions
Trans. IDInvestment DateExit DateInvestor(s)Deal Size (M)Seller(s)
Access 2 Transactions
Sign up to view the full investment history — dates, deal sizes, investors & sellers
Sign Up Free Log In
Virbac SA - SENTINEL U.S. Rights M&A Activity
# Company Transaction Date Close Date Sector Country
View M&A Acquisitions
Sign up to explore the full acquisition & merger history
Sign Up Free Log In
Key Executives & Professionals
View Executives & Professionals
Sign up to access board members, senior management & key contacts
Sign Up Free Log In
Frequently Asked Questions
What does Virbac SA - SENTINEL U.S. Rights do?
According to available private market data, Virbac SA - SENTINEL U.S. Rights operates in the Life Science sector. Private market activity associated with the company includes investment from Merck & Co., Inc.. The company is headquartered in New Jersey (NJ). Virbac SA - SENTINEL U.S. Rights is inclu
Where is Virbac SA - SENTINEL U.S. Rights headquartered?
Virbac SA - SENTINEL U.S. Rights is headquartered in New Jersey (NJ), United States.
When was Virbac SA - SENTINEL U.S. Rights founded?
Founded year information for Virbac SA - SENTINEL U.S. Rights is available on AcquityData.
What sector is Virbac SA - SENTINEL U.S. Rights in?
Virbac SA - SENTINEL U.S. Rights operates in the Life Science sector.
Who are the investors in Virbac SA - SENTINEL U.S. Rights?
Current investors in Virbac SA - SENTINEL U.S. Rights include Merck & Co., Inc.. Sign up to AcquityData to view full investor details, deal dates and transaction history.
How many M&A transactions has Virbac SA - SENTINEL U.S. Rights been involved in?
Virbac SA - SENTINEL U.S. Rights has 2 transactions tracked on AcquityData. Sign up to view full investment history including dates, deal sizes, investors and sellers.

Unlock the full Virbac SA - SENTINEL U.S. Rights profile

Ownership & Investors M&A History Financials Key Executives Advisors & Lenders

Access Virbac SA - SENTINEL U.S. Rights's complete ownership history, M&A activity, investors, advisors and executives in one connected platform.

Start Free Trial